Filing Details
- Accession Number:
- 0001209191-13-037075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-17 18:31:12
- Reporting Period:
- 2013-07-17
- Filing Date:
- 2013-07-17
- Accepted Time:
- 2013-07-17 18:31:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1254419 | Medassets Inc | MDAS | Services-Prepackaged Software (7372) | 510391128 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1500430 | M Lance Culbreth | 100 North Point Center East Suite 200 Alpharetta GA 30022 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-17 | 2,000 | $9.29 | 18,106 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-17 | 4,500 | $20.45 | 13,606 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-07-17 | 2,000 | $0.00 | 2,000 | $9.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2017-09-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Restricted Stock | 2,931 | Direct | |
Restricted Stock | 1,466 | Direct | |
Restricted Stock | 1,466 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | $9.68 | 2016-07-05 | 3,200 | 3,200 | Direct | |
Common Stock | Stock Options (Right to Buy) | $15.95 | 2018-03-25 | 9,126 | 9,126 | Direct | |
Common Stock | Stock-Settled Stock Appreciation Rights | $14.74 | 2016-01-05 | 12,133 | 12,133 | Direct | |
Common Stock | Stock-Settled Stock Appreciation Rights | $18.14 | 2017-11-23 | 3,777 | 3,777 | Direct | |
Common Stock | Stock-Settled Stock Appreciation Rights | $18.14 | 2017-11-23 | 48,000 | 48,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-07-05 | 3,200 | 3,200 | Direct |
2018-03-25 | 9,126 | 9,126 | Direct |
2016-01-05 | 12,133 | 12,133 | Direct |
2017-11-23 | 3,777 | 3,777 | Direct |
2017-11-23 | 48,000 | 48,000 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2012.
- The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
- The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
- The reporting person was granted these stock options on September 10, 2007 and are fully vested.
- The reporting person was granted these stock options on July 5, 2006 and are fully vested.
- The reporting person was granted these stock options on March 25, 2008 and are fully vested.
- The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009 and are fully vested.
- The reporting person was granted these SSARs on November 23, 2010 and are fully vested.
- The reporting person was granted these SSARs on November 23, 2010. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2010 such that 100% of the SSARs will be fully vested on October 1, 2015.